Olfr1090 activators encompass a group of chemical compounds primarily functioning as phosphodiesterase (PDE) inhibitors, indirectly enhancing the functional activity of Olfr1090 through the modulation of cyclic AMP (cAMP) levels, a key secondary messenger in olfactory transduction. Forskolin, for instance, directly stimulates adenylate cyclase, leading to increased cAMP levels and activating protein kinase A (PKA). This activation is crucial in olfactory signaling as PKA phosphorylates various substrates, thereby sensitizing Olfr1090 to its odorant ligands. Similarly, compounds like IBMX, Caffeine, Isoproterenol, and Rolipram, all inhibit different forms of phosphodiesterases, resulting in elevated cAMP levels. This cAMP accumulation reinforces the cAMP-dependent olfactory signaling pathways, indirectly augmenting Olfr1090's activity. The mechanism of action for these activators, although diverse in their target specificity, converges on the amplification of cAMP signaling, a critical modulator of olfactory neuron responsiveness.
Additionally, chemicals like Zaprinast, Vinpocetine, Sildenafil, Papaverine, Theophylline, Vardenafil, and Anagrelide, while varying in their specific phosphodiesterase targets, collectively contribute to the enhancement of Olfr1090 activity by increasing intracellular cAMP concentrations. This rise in cAMP further potentiates the signaling cascade involved in olfactory perception. Sildenafil and Vardenafil, for example, are selective for PDE5, and their inhibition leads to cAMP accumulation, indirectly boosting Olfr1090-mediated olfactory signaling. Theophylline, a non-selective PDE inhibitor, and Anagrelide, a PDE3 inhibitor, also elevate cAMP levels, further amplifying the functional responsiveness of Olfr1090 in olfactory neurons. Collectively, these Olfr1090 activators, through their targeted effects on cAMP signaling, facilitate the enhancement of Olfr1090-mediated functions in olfactory signal transduction, demonstrating the intricate interplay between cAMP modulation and olfactory receptor activation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Increases intracellular cAMP, which activates PKA, enhancing Olfr1090's sensitivity to odorants as cAMP is crucial in olfactory signaling. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Inhibits phosphodiesterases, raising cAMP levels and indirectly augmenting Olfr1090 activity by reinforcing cAMP-dependent olfactory transduction pathways. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
As a phosphodiesterase inhibitor, it elevates cAMP levels, indirectly enhancing Olfr1090 signaling in olfactory neurons. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
A β-adrenergic receptor agonist that increases cAMP in cells, potentially enhancing Olfr1090-mediated olfactory signal transduction. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Selectively inhibits PDE4, elevating cAMP and possibly enhancing Olfr1090 function in olfactory neurons by strengthening cAMP-dependent signaling. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $103.00 $245.00 | 8 | |
Inhibits PDE5, increasing cAMP levels which could indirectly augment Olfr1090 signaling in olfactory pathways. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Inhibits PDE1, raising cAMP levels, which may indirectly strengthen Olfr1090-mediated olfactory signal transduction. | ||||||
Papaverine | 58-74-2 | sc-279951 sc-279951A sc-279951B | 10 mg 50 mg 100 mg | $153.00 $265.00 $459.00 | ||
Non-selective phosphodiesterase inhibitor, increases cAMP levels, possibly aiding in the activation of Olfr1090 in olfactory pathways. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $31.00 $83.00 | 6 | |
Phosphodiesterase inhibitor, raises cAMP concentration, which could indirectly enhance Olfr1090 activity in olfactory neurons. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $516.00 $720.00 $16326.00 | 7 | |
Inhibits PDE5, leading to increased cAMP levels and potentially amplifying Olfr1090 signaling in the olfactory system. | ||||||